IL3 and Alzheimer disease: For example, using a microfluidic device containing iPSC derived microglia on one side and iPSC derived neurons and astrocytes on the other side, McAlpine et al. elegantly demonstrated that IL-3 secreted by astrocytes induces increased migration of microglia; this IL-3 dependent activation provided benefits in a mouse model of AD through reduced plaque burden (100).